Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer

Patients’ experience and compliance with extended low molecular weight heparin prophylaxis post-surgery for gynecological cancer: a prospective observational study

(2019) Zibi Marchocki et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

(2019) Nigel S. Key et al.   JOURNAL OF CLINICAL ONCOLOGY

Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis

(2018) M. Di Nisio et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer

(2018) Gary H. Lyman et al.   THROMBOSIS RESEARCH

Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy

(2017) Patricia S. Greco et al.   OBSTETRICS AND GYNECOLOGY

Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism: A Population-Based Longitudinal Study

(2016) Kevin P. Cohoon et al.   AMERICAN JOURNAL OF MEDICINE

Incidence and the timing of thromboembolic events in ovarian cancer patients undergoing neoadjuvant chemotherapy

(2016) P. Szmal et al.   GYNECOLOGIC ONCOLOGY

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

(2016) Alexi A. Wright et al.   JOURNAL OF CLINICAL ONCOLOGY

The humanistic and economic burden of venous thromboembolism in cancer patients

(2015) Georgia Kourlaba et al.   BLOOD COAGULATION & FIBRINOLYSIS

Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma

(2015) Koji Matsuo et al.   EUROPEAN JOURNAL OF CANCER

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

(2015) Sean Kehoe et al.   LANCET

The survival detriment of venous thromboembolism with epithelial ovarian cancer

(2014) Camille C. Gunderson et al.   GYNECOLOGIC ONCOLOGY

Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival

(2013) Feras Abu Saadeh et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?

(2012) Ignace Vergote et al.   GYNECOLOGIC ONCOLOGY

Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer

(2011) Melissa M. Thrall et al.   GYNECOLOGIC ONCOLOGY

Prediction of venous thromboembolism in cancer patients

(2010) C. Ay et al.   BLOOD

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

(2010) Ignace Vergote et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development and validation of a predictive model for chemotherapy-associated thrombosis

(2008) A. A. Khorana et al.   BLOOD

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

(2008) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis

(2008) S. IODICE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Cardiovascular Risk Factors and Venous Thromboembolism

(2007) Walter Ageno et al.   CIRCULATION